Biosensors Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Biosensors Market report segments the industry into By Type (Wearable Biosensors, Non-Wearable Biosensors), By Application (Cancer Diagnosis, Glucose Monitoring, and more), By Technology (Electrochemical Biosensors, Optical Biosensors, and more), By End-User (Hospitals and Clinics, and more), and Geography (North America, Europe, and more).

Biosensors Market Size

Compare market size and growth of Biosensors Market with other markets in Healthcare Industry

Biosensors Market Analysis

The Biosensors Market size is estimated at USD 10.97 billion in 2025, and is expected to reach USD 17.11 billion by 2030, at a CAGR of 9.30% during the forecast period (2025-2030).

The biosensor market is growing due to factors such as the increasing prevalence of chronic and lifestyle diseases and the rising demand for point-of-care testing (POCT).

The rising incidence of diabetes, cardiovascular diseases, and cancer is fueling the need for biosensors that monitor glucose levels, heart rate, and biomarkers, which is anticipated to drive the market growth. For instance, according to the data updated by the International Diabetes Federation in January 2025, the organization estimated that a staggering 783 million people, or roughly 1 in 8 adults, will be living with diabetes globally by 2045. Additionally, according to the data published by the British Heart Foundation in September 2024, approximately 620 million individuals were affected by heart and circulatory diseases globally in 2024. Thus, the significant prevalence of these chronic conditions, such as diabetes and heart disorders, is expected to significantly drive the adoption and innovation of biosensors in the market.

The biosensors market has been witnessing significant advancements, driven by the increasing initiatives adopted by the market players. For instance, in September 2024, Monod Bio launched NovoLISA (de Novo protein-Linked Instantaneous Solution-based Assay). This rapid biosensor assay platform delivers results in just 15 minutes, significantly faster than traditional methods like ELISA, commonly used in Research Use Only (RUO) settings. NovoLISA's speed and efficiency stem from combining two proprietary technologies: the LuxSit Pro luciferase reporter and de novo binding protein reagents. Additionally, in January 2023, SCHOTT launched its first United States facility, expanding its capacity to develop and manufacture diagnostic and life science products. The primary focus of this new facility will be the production of custom DNA and protein biosensors. These biosensors will be used to detect and quantify multiple biomarkers associated with infectious diseases, autoimmune disorders, and cancers by targeting genes and proteins of either the infecting agent or those in the affected patient. Such developments underscore the growing innovation and investment in the biosensors market, which is expected to be pivotal in addressing the evolving needs of the healthcare and diagnostics sectors.

Thus, the biosensors market is expanding due to the rising incidence of chronic illnesses and ongoing advancements and investments from market participants. However, the high costs associated with development and production could potentially slow down market growth in the coming years.

Biosensors Industry Overview

The biosensors market is moderately fragmented, with many participants including large multinational companies and smaller, emerging startups. Market players focus on various applications such as glucose monitoring, cardiovascular monitoring and infectious disease detection, among others, creating a diverse market landscape. Key market players include Abbott Laboratories, Medtronic Plc, Dexcom, Inc., F. Hoffmann La Roche Ltd. and Koninklijke Philips N.V., among others.

Biosensors Market Leaders

  1. Abbott Laboratories

  2. Medtronic Plc

  3. Dexcom, Inc.

  4. F. Hoffmann La Roche Ltd.

  5. Koninklijke Philips N.V.

  6. *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF

Biosensors Market News

  • October 2024: Bruker Corporation acquired Dynamic Biosensors GmbH, a Munich-based company in biosensor technology. This acquisition expanded Bruker's biosensors business with enhanced biophysical analysis capabilities, providing enhanced insights into molecular interactions and kinetics, including molecule-cell interactions, for drug discovery and basic research applications.
  • April 2024: Biolinq Inc. secured USD 58 million in funding from various investors such as Alpha Wave Ventures and Niterra's corporate venture capital arm (operated with Pegasus Tech Ventures), among others. The funds will be used to complete a critical United States clinical trial for the company's intradermal glucose sensor and to support its subsequent Food and Drug Administration (FDA) submission. The company's user-friendly wearable patch employs a network of miniature electrochemical sensors to measure glucose levels from just below the skin's surface, integrating this glucose data with activity levels in a single device.

Biosensors Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic and Lifestyle Diseases
    • 4.2.2 Rising Demand for Point-of-Care Testing (POCT)
  • 4.3 Market Restraints
    • 4.3.1 High Development and Manufacturing Costs
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Type
    • 5.1.1 Wearable Biosensors
    • 5.1.2 Non-Wearable Biosensors
  • 5.2 By Application
    • 5.2.1 Cancer Diagnosis
    • 5.2.2 Glucose Monitoring
    • 5.2.3 Cardiovascular Monitoring
    • 5.2.4 Infectious Disease Detection
    • 5.2.5 Drug Monitoring
    • 5.2.6 Other Applications
  • 5.3 By Technology
    • 5.3.1 Electrochemical Biosensors
    • 5.3.2 Optical Biosensors
    • 5.3.3 Thermal Biosensors
    • 5.3.4 Piezoelectric Biosensors
    • 5.3.5 Nanotechnology-Based Biosensors
  • 5.4 By End-User
    • 5.4.1 Hospitals and Clinics
    • 5.4.2 Home Healthcare Settings
    • 5.4.3 Other End-User
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Medtronic Plc
    • 6.1.3 F.Hoffmann La Roche Ltd.
    • 6.1.4 LifeSignals
    • 6.1.5 Dexcom, Inc.
    • 6.1.6 Bio-Rad Laboratories, Inc.
    • 6.1.7 Nova Biomedical
    • 6.1.8 AgaMatrix, Inc.
    • 6.1.9 Nanomix Inc.
    • 6.1.10 MediWise Ltd.
    • 6.1.11 Koninklijke Philips N.V.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Biosensors Industry Segmentation

A biosensor is a tool that uses a biological component like enzymes, antibodies, or DNA to detect and measure specific substances and combines this biological element with a physical or chemical detector. Biosensors are used for diagnosing diseases, tracking health conditions, and managing treatments because they are accurate, fast, and often don't require invasive procedures. The biosensors market is segmented into type, application, technology, end-user and geography. By type, the market is segmented into wearable biosensors and non-wearable biosensors. By application, the market is segmented into diagnostics, therapeutics and patient monitoring. By diagnostics, cancer diagnosis, glucose monitoring, cardiovascular monitoring, infectious disease detection, drug monitoring and other applications (point-of-care testing, personalized medicine and pregnancy testing, among others). By technology, the market is segmented into electrochemical biosensors, optical biosensors, thermal biosensors, piezoelectric biosensors and nanotechnology-based biosensors. By end-user, the market is segmented into hospitals and clinics, home healthcare settings, and other end-users (research institutes and diagnostic laboratories). By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. For each segment, the market size is provided in terms of USD value.

By Type Wearable Biosensors
Non-Wearable Biosensors
By Application Cancer Diagnosis
Glucose Monitoring
Cardiovascular Monitoring
Infectious Disease Detection
Drug Monitoring
Other Applications
By Technology Electrochemical Biosensors
Optical Biosensors
Thermal Biosensors
Piezoelectric Biosensors
Nanotechnology-Based Biosensors
By End-User Hospitals and Clinics
Home Healthcare Settings
Other End-User
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
By Type
Wearable Biosensors
Non-Wearable Biosensors
By Application
Cancer Diagnosis
Glucose Monitoring
Cardiovascular Monitoring
Infectious Disease Detection
Drug Monitoring
Other Applications
By Technology
Electrochemical Biosensors
Optical Biosensors
Thermal Biosensors
Piezoelectric Biosensors
Nanotechnology-Based Biosensors
By End-User
Hospitals and Clinics
Home Healthcare Settings
Other End-User
Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Biosensors Market Research FAQs

How big is the Biosensors Market?

The Biosensors Market size is expected to reach USD 10.97 billion in 2025 and grow at a CAGR of 9.30% to reach USD 17.11 billion by 2030.

What is the current Biosensors Market size?

In 2025, the Biosensors Market size is expected to reach USD 10.97 billion.

Who are the key players in Biosensors Market?

Abbott Laboratories, Medtronic Plc, Dexcom, Inc., F. Hoffmann La Roche Ltd. and Koninklijke Philips N.V. are the major companies operating in the Biosensors Market.

Which is the fastest growing region in Biosensors Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Biosensors Market?

In 2025, the North America accounts for the largest market share in Biosensors Market.

What years does this Biosensors Market cover, and what was the market size in 2024?

In 2024, the Biosensors Market size was estimated at USD 9.95 billion. The report covers the Biosensors Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Biosensors Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Access Report